Prescription Digital Therapeutics (PDTx) Market Growth Rate, Demands, Future Outlook 2027 with Top Key Players: SAMSUNG, GAIA AG, Pear Therapeutics

The newly added report by Data Bridge Market Research entitled “Global Prescription Digital Therapeutics (PDTx) Market 2021” By Manufacturers, Regions, Type and Application and Forecast gives productive ideas, updated information with the latest market intelligence and which supports with the strategic investment decisions. The exploration investigators give a detailed depiction of the value chain and its wholesaler network’s examination. This market study gives far reaching information that improves the understanding, scope, and utilization of this report. This report covers current market trends, opportunities, challenges, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, technological innovations and detailed competitive analysis of the industry players in the market.

Prescription Digital Therapeutics (PDTx) Market

The prescription digital therapeutics (PDTx) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 21.6% in the forecast period of 2020 to 2027 and is expected to reach USD 2,698.99 million by 2027. Rising prevalence of metabolic diseases such as diabetics and continuous monitoring of diseases everywhere and extensive research & development activity in prescription digital therapeutics (PDTx) are the major drivers which propelled the demand of the prescription digital therapeutics (PDTx) market in the forecast period.

Download Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @

The major players covered in Prescription Digital Therapeutics (PDTx) are:

  • Omada Health, Inc
  • ResMed
  • Pear Therapeutics, Inc
  • Welldoc’s Bluestar
  • Solera Network
  • Akili Interactive Labs, Inc
  • Better Therapeutics, LLC
  • BigHealth
  • Biofourmis
  • Click Therapeutics, Inc
  • Happify, Inc
  • Limbix Health Inc

Prescription Digital Therapeutics (PDTx) market research report aids in achieving a sustainable growth in the market, by providing a well-versed, specific and most relevant product and market information. The market drivers and restraints have been explained using SWOT analysis. Business intelligence has been applied to generate this market report which is a vital aspect when it comes to accomplish thorough and wide-ranging market insights. This market report will also surely help in the journey to achieve the business growth and success. The global Prescription Digital Therapeutics (PDTx) report also provides an insightful overview of product specification, technology, applications, product type and production analysis considering major factors such as revenue, cost, and gross margin.

Prescription Digital Therapeutics (PDTx) Market Segmentation:

By Mechanism (Input Mechanisms, Output Mechanisms)

By Category (Medication Augmentation, Medication Replacement)

By Treatment (Outpatient Treatment, Monotherapy), Software (Software for Respiratory Conditions, Software for Mental Health, Software for Opioid Use Disorder, Software for Diabetes, Others)

By Services (Behavioral Microservices, Medical Microservices), App Accessibility (Android, iOS, Windows)

By App Type (Native Apps, Web Apps)

By Application (Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions, Others), Patients (Children, Adults)

Prescription Digital Therapeutics (PDTx) Market Country Level Analysis

  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
  • South America (Brazil etc.)
  • Middle East and Africa (Egypt and GCC Countries)

Get Complete Latest TOC of This Report @

Table Of Content

Research Coverage: This is the first part of the research that covers market segmentation outlines, years studied, analysis targets, major global Innovation Management Platforms manufacturers, and product range.

Key Market Features: The report here puts the spotlight on market output, revenue, usage, and potential. It also brings market trends, drivers, restraints and macroscopic indicators to light.

Profiles of companies: This section includes a broad examination of key players in the global Prescription Digital Therapeutics (PDTx) market based on various factors such as the latest advances, market share and gross margins. This provides an analysis of SWOT, too.

Key Strategic Developments: All the regions evaluated in the study are examined here based on key factors such as volume, sales, market share, import, and export.

Regional demand: Each domestic market discussed here is evaluated based on the global market’s share of sales and output.

Product market penetration: It comprises of the study of costs, sales and industry overview by product type.


Competitive Landscape and Prescription Digital Therapeutics (PDTx) Market Share Analysis

The major companies which are dealing in the global prescription digital therapeutics (PDTx) market report are Omada Health, Inc., ResMed, SAMSUNG, GAIA AG, Pear Therapeutics, Inc., Welldoc’s Bluestar, Solera Network, Akili Interactive Labs, Inc., Better Therapeutics, LLC, BigHealth, Biofourmis, Click Therapeutics, Inc., Happify, Inc., Limbix Health, Inc., Naturalcycles Nordic AB, NuvoAir AB, Sensyne Health plc, Voluntis, Xealth among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the prescription digital therapeutics (PDTx) market.

For instance,

  • In June 2020, Pear Therapeutics, Inc. announces RESET prescription digital therapeutics market authorization from the Health Science Authority in Singapore for the treatment of adults with Substance Use Disorder.

Global Prescription Digital Therapeutics (PDTx) Market Scope and Market Size

On the basis of mechanism, the prescription digital therapeutics (PDTx) market is segmented into input mechanisms and output mechanisms.

On the basis of category, the prescription digital therapeutics (PDTx) market is segmented into medication augmentation and medication replacement.

On the basis of treatment, the prescription digital therapeutics (PDTx) market is segmented into outpatient treatment and monotherapy.

On the basis of software, the prescription digital therapeutics (PDTx) market is segmented into software for respiratory conditions, software for mental health, software for opioid use disorder, software for diabetes and others.

On the basis of services, the prescription digital therapeutics (PDTx) market is segmented into behavioral microservices and medical microservices.

On the basis of app accessibility, the prescription digital therapeutics (PDTx) market is segmented into android, iOS and windows.

On the basis of app type, the prescription digital therapeutics (PDTx) market is segmented into native app and web app.

On the basis of application, the prescription digital therapeutics (PDTx) market is segmented into substance use disorder (SUD), opioid use disorder (OUD), attention deficit/hyperactivity disorder (ADHD), alzheimer’s disease, major depressive disorder (MDD), insomnia, epilepsy, movement disorder, multiple sclerosis, migraine, autism spectrum disorder, oncology, inflammation, respiratory, cardiovascular, pain management, metabolic conditions and others.

On the basis of patients, the prescription digital therapeutics (PDTx) market is segmented into children and adults.

Influence Highlights Of The Prescription Digital Therapeutics (PDTx) Market Report:

  • A comprehensive evaluation of all opportunities and risks in the Prescription Digital Therapeutics (PDTx) market.
  • Prescription Digital Therapeutics (PDTx) market current developments and significant occasions.
  • A deep study of business techniques for the development of the market-driving players.
  • Conclusive study about the improvement plot of the market for approaching years.
  • Top to the bottom approach of market-express drivers, targets, and major littler scale markets.
  • Favourable impressions inside imperative mechanical and publicize the latest examples striking the Global Prescription Digital Therapeutics (PDTx) market.
  • Impact of COVID-19 as well as how the market is functioning post-COVID-19.
  • Representation of regional analysis along with country level data.
  • An estimation of the entire market along with data to showcase how exactly the Prescription Digital Therapeutics (PDTx)market is changing.

Make An Enquiry and Ask For Customized Report@

Also, report purchase provides access to: Report in PDF format for all License types, Report in Excel + PDF format for Team and Corporate Licenses, Free analyst support for 6 months, Free report update with the Single User License, Enterprise User and factbook, 15% free customization equal to 60 analyst hours

About Data Bridge Market Research Private Ltd:

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @

Related Articles

Back to top button